Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × Folfox protocol × Clear all

NCT06871527 2025-03-12

Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT03526835 2025-01-29

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00854854 2009-05-18

Efficacy Study of TKcell in Advanced Gastric Cancer

Phase 1/2 Unknown

Gastrointestinal

Stomach Neoplasms